The latest results from four clinical trials: TRUE-AHF; EUCLID; Pioneer AF-PCI; and ART.
Using low-oxygen therapy to regenerate growth in damaged hearts; exercise to prevent heart failure with preserved ejection fraction; the clinical clues and signs of advanced heart failure; exercise intolerance in heart patients: chronotropic incompetence or reluctance.
Circulation, the leading journal in cardiovascular medicine, is now based at UTSW; measuring troponin in an outpatient setting; glucose control for patients with acute coronary syndromes.
Examining the obesity paradox in STEMI patients; understanding cholesterol efflux to mitigate heart attack and stroke; coronary calcium scores of zero: when nothing is really something.
Determining excellence in transcatheter aortic valve replacement: what to expect in 2017.
UT Southwestern is always well represented at the American Heart Association Scientific Sessions. Dr. John Warner, CEO of UT Southwestern University Hospitals and President-Elect of the AHA, explains the significance of UTSW’s participation and what it means for referring physicians.